Press "Enter" to skip to content

Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s continued efforts to bring competition to the insulin market to lower prices and expand access

FDA is announcing a public hearing to discuss access to affordable insulin products.

Original source:

Also Read:   Coronavirus (COVID-19) Update: March 5, 2021